Study: Adolescent Cannabis Use Doubles Psychotic and Bipolar Disorder Risk
Adolescent cannabis psychotic risk is significantly elevated, doubling the likelihood of psychotic and bipolar disorders. This study highlights the critical neurodevelopmental vulnerability during teenage years. Clinicians should prioritize screening and…
Mom’s Homemade Medical Cannabis Recipe Now Sold at Georgia Dispensaries
Patient-derived cannabis formulations are now being sold at Georgia dispensaries, raising important safety and quality concerns. This shift impacts pediatric autism treatment options and clinical guidance. Clinicians should stay informed about these…
‘Green Lab’ Aids Oregon Officers in Cannabis-Impaired Driving Recognition
Cannabis-impaired driving recognition is improving through Oregon's innovative 'green lab' training for law enforcement. This standardized approach helps officers identify impairment more reliably. Clinicians should incorporate this knowledge when…
Daily Digest: Cannabis Adolescent Psychiatric Risk Data Study
This cannabis adolescent psychiatric risk data study highlights new concerns about marijuana use in teens and its association with psychiatric conditions. The developing adolescent brain is particularly vulnerable to cannabis effects, increasing risks…
Daily Digest: Last 48 Hours: Cognitive Safety, End-of-Life Access, and the Impairment Testing Problem — March 06, 2026
This daily digest highlights the impairment testing problem cannabis presents in clinical and policy contexts. It also covers cognitive safety and end-of-life access issues. The focus on impairment testing problem cannabis is crucial for advancing…
Veterans Groups Urge Congress to Expand Psychedelic and Cannabis Access
Veterans cannabis psychedelic therapy access is increasingly recognized as vital for treatment-resistant PTSD. Veterans currently face risks seeking therapies outside the VA system. Expanding access would improve clinical supervision and continuity of…
Natural Neuroprotection: Exploring Non-Psychoactive Cannabinoids
Non-psychoactive cannabinoids neuroprotection offers promising avenues for neurological health. These compounds interact with the endocannabinoid system to modulate inflammation and oxidative stress. While preclinical data is strong, clinical evidence…
Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults
A recent study found no link between lifetime cannabis use cognitive decline in older adults. This evidence suggests that past cannabis exposure does not increase dementia risk. Clinicians can use these findings to inform patient discussions about…
Daily Digest: Cognitive Safety, End-of-Life Cannabis Access, and Regulatory Challenges — March 06, 2026
End-of-life cannabis access remains a critical issue for patients and healthcare providers. This digest highlights regulatory gaps and hospital policies impacting terminally ill patients. Cognitive safety in older adults using cannabis is also examined…
Daily Digest: Last 9 Hours: Cognitive Safety Data, End-of-Life Access, and Regulatory Friction — March 05, 2026
This digest highlights recent research on cognitive safety in older adults using cannabis, addressing dementia risk and clinical implications. It also covers advances in end-of-life cannabis access and ongoing regulatory friction. These insights provide…